includes the formulation of artificial enzymes or oxygen transporters with non-dissociable heme; such systems are expected to have an elongated lifetime, have increased resistance to proteolytic cleavage, and may be capable of functioning over a wide range of conditions (e.g. high temperature, low pH) for industrial or biomedical applications.